Dr. Nigel Key and Dr. Anna Falanga join us for a conversation on the updated ASCO VTE prophylaxis and treatment in patients with cancer guideline. They discuss recent evidence assessing apixaban for ...

After publication of potentially practice-changing clinical trials, identified through ASCO's signals approach to updating, an updated systematic review was performed for two guideline questions: ...

At the dawn of the 21st century, venous thromboembolism (VTE) treatment remained in the dark ages. Backed by an MD and a legacy of paternalistic practice, we convinced patients to do what now seems ...

Diagnosis and Prophylaxis Treatment Strategies References 1. Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: ...

Patients who have suffered from a first episode of unprovoked venous thromboembolism (VTE) have an eight times higher risk of recurrence if they stop treatment after repeated negative D-dimer tests, ...

Direct oral anticoagulants (DOACs) have transformed venous thromboembolism (VTE) treatment by offering predictable pharmacokinetics and eliminating routine monitoring requirements. Despite robust ...

For patients younger than 21 who have provoked venous thromboembolism (VTE), shortening the length of anticoagulation to prevent a recurrent event is no worse than using it for the standard 3 months, ...

The quality of care of patients hospitalized with venous thromboembolism (VTE) significantly improved between 2005 and 2009, and researchers suggest these improvements may be due to the implementation ...

The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...